The placebo effect

Psychiatric Bulletin

Volumn 30, Issue 5, 2006, Pages 185-188

  Rajagopal, Sundararajan ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIRHEUMATIC AGENT; DOPAMINE; ENDORPHIN; FLUOXETINE; IMIPRAMINE; NALOXONE; NEUROTRANSMITTER; OPIATE; PLACEBO; PSYCHOTROPIC AGENT;

ALTERNATIVE MEDICINE; ANALGESIA; ARTICLE; BEHAVIOR; CLINICAL PRACTICE; CLINICAL TRIAL; COMMON COLD; DEPRESSION; HEADACHE; HUMAN; HYPERALGESIA; HYPERTENSION; MEDICAL ETHICS; MENTAL DISEASE; MOOD; NAUSEA; ONCHOCERCIASIS; PREDICTION; PSYCHOLOGICAL ASPECT; RELAPSE; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 33646385931     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.30.5.185     Document Type: Article

References (19)

1. BEECHER, H. K. (1955) The powerful placebo. JAMA, 159, 1602-1606.
2. BENEDETTI, F., AMANZIO, M., CASADIO C., et al (1997) Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain, 71, 135-140.
3. BENEDETTI, F., MAGGI, G., LOPIANO L., et al (2003) Open versus hidden medical treatments: the patients' knowledge about a therapy affects the therapy outcome. Prevention & Treatment, 6. http://content.apa.org/journals/pre/6/1/1
4. BRANTHWAITE, A. & COOPER, P. (1981) Analgesic effects of branding in treatment of headaches. BMJ, 282, 1576-1578.
5. CASPER, R. C.,TOLLEFSON, G. D. & NILSSON, M. E. (2001) No gender differences in placebo responses of patients with major depressive disorder. Biological Psychiatry, 15, 158-160.
6. GREVERT, P., ALBERT, L. H. & GOLDSTEIN, A. (1983) Partial antagonism of placebo analgesia by naloxone. Pain, 16, 129-143.
7. HROBJARTSSON, A. & GOTZSCHE, P. C. (2001) Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine, 344, 1594-1602.
8. KIENLE, G. S. & KIENE, H. (1997) The powerful placebo effect: fact or fiction? Journal of Clinical Epidemiology, 50, 1311-1318.
9. KIRSCH, I. & SAPIRSTEIN, G. (1998) Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication. Prevention & Treatment, 1, http://content.apa.org/journals/pre/1/1/2
10. LEUCHTER, A. F., COOK, I. A.,WITTE, E. A., et al (2002) Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry, 159, 122-129.
11. LINDE, K., STRENG, A., JURGENS, S., et al (2005) Acupuncture for patients with migraine. JAMA, 293, 2118-2125.
12. MARGRAF, J., EHLERS, A., ROTH, W.T., et al (1991) How 'blind' are double-blind studies? Journal of Consulting and Clinical Psychology, 59, 184-187.
13. McDONALD, C. J., MAZZUCA, S. A. & McCABE, G. P., Jr (1983) How much of the placebo 'effect' is really statistical regression? Statistical Medicine, 2, 417-427.
14. PECK, C. & COLEMAN, G. (1991) Implications of placebo theory for clinical research and practice in pain management. Theoretical Medicine, 12, 247-270.
15. QUITKIN, F. M., RABKIN, J. G., STEWART, J.W., et al (1991) Heterogeneity of clinical response during placebo treatment. American Journal of Psychiatry, 148, 193-196.
16. ROTHMAN, K. J. & MICHELS, K. B. (1994) The continuing unethical use of placebo controls. New England Journal of Medicine, 331, 394-398.
17. STEWART, J.W., QUITKIN, F. M., McGRATH, P. J. (1998) Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Archives of General Psychiatry, 55, 334-343.
18. Ter RIET, G., De CRAEN, A. J., De BOER, A., at at (1998) is placebo analgesia mediated by endogenous opioids? A systematic review. Pain, 76, 273-275.
19. VINAR, O. (1969) Dependence on a placebo: a case report. British Journal of Psychiatry, 115, 1189-1190.